IL-1 receptor blockade alleviates pulmonary inflammation and halt the progressive decline in lung function, indicating that IL-1 cytokines are the key factors of pulmonary fibrosis [1,3,12]. The gene discussed is IL1B; the disease is pulmonary fibrosis.